NEW YORK (GenomeWeb News) – Qiagen expects to raise gross proceeds of around $557 million from a public offering of newly issued common shares.

The firm said last night that it will offer 27.5 million shares at a price of $20.25 per share. Qiagen's shares closed at $21.02 in Thursday trade on the Nasdaq.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.